Skip to main content
NCBI home page
Gut logoLink to Gut
. 1996 Dec;39(6):807–810. doi: 10.1136/gut.39.6.807

Ornithine decarboxylase activity is a marker of premalignancy in longstanding Helicobacter pylori infection.

S E Patchett 1, P H Katelaris 1, Z W Zhang 1, E M Alstead 1, P Domizio 1, M J Farthing 1
PMCID: PMC1383451  PMID: 9038661

Abstract

BACKGROUND: Longstanding Helicobacter pylori infection may increase the risk of developing gastric adenocarcinoma. The sequence of chronic active gastritis leading to gastritis with atrophy and subsequent intestinal metaplasia is thought to be a key step in gastric carcinogenesis. Ornithine decarboxylase (ODC) activity is increased in some pre-malignant gastrointestinal conditions and is essential for malignant transformation in vitro. AIMS: To measure ODC activity in the antrum of H pylori infected and non-infected subjects and to relate this to histological abnormalities associated with recent and longstanding H pylori infection. METHODS: Six antral mucosal biopsy specimens were obtained from 75 patients for detailed histological assessment and measurement of ODC activity. Samples were measured in duplicate and results expressed as median, interquartile range in pmol/mg protein/h. RESULTS: ODC activity was significantly higher in H pylori positive (164, 88-259 pmol/mg/h) than H pylori negative subjects (99.8, 55-158 pmol/mg/h, p = 0.003). However the presence of gastritis, irrespective of the severity of inflammation or activity had no influence on ODC activity. Gastritis with atrophy was associated with increased ODC activity, which was closely related to the severity of the atrophy (p = 0.01). Similarly, ODC activity was significantly increased in subjects with intestinal metaplasia (196, 83-25) compared with those without intestinal metaplasia (111.7, 65-175, p < 0.04). CONCLUSIONS: These results indicate that the histological changes associated with longstanding H pylori infection rather than inflammation alone are associated with increased polyamine biosynthetic activity. This may be relevant to H pylori associated gastric carcinogenesis.

Full text

PDF
807

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. An international association between Helicobacter pylori infection and gastric cancer. The EUROGAST Study Group. Lancet. 1993 May 29;341(8857):1359–1362. [PubMed] [Google Scholar]
  2. Auvinen M., Paasinen A., Andersson L. C., Hölttä E. Ornithine decarboxylase activity is critical for cell transformation. Nature. 1992 Nov 26;360(6402):355–358. doi: 10.1038/360355a0. [DOI] [PubMed] [Google Scholar]
  3. Beaven M. A., Wilcox G., Terpstra G. K. A microprocedure for the measurement of 14CO2 release from [14C]carboxyl-labeled amino acids. Anal Biochem. 1978 Feb;84(2):638–641. doi: 10.1016/0003-2697(78)90089-1. [DOI] [PubMed] [Google Scholar]
  4. Brenes F., Ruiz B., Correa P., Hunter F., Rhamakrishnan T., Fontham E., Shi T. Y. Helicobacter pylori causes hyperproliferation of the gastric epithelium: pre- and post-eradication indices of proliferating cell nuclear antigen. Am J Gastroenterol. 1993 Nov;88(11):1870–1875. [PubMed] [Google Scholar]
  5. Cahill R. J., Xia H., Kilgallen C., Beattie S., Hamilton H., O'Morain C. Effect of eradication of Helicobacter pylori infection on gastric epithelial cell proliferation. Dig Dis Sci. 1995 Aug;40(8):1627–1631. doi: 10.1007/BF02212681. [DOI] [PubMed] [Google Scholar]
  6. Correa P. A human model of gastric carcinogenesis. Cancer Res. 1988 Jul 1;48(13):3554–3560. [PubMed] [Google Scholar]
  7. Cuzick J. A Wilcoxon-type test for trend. Stat Med. 1985 Jan-Mar;4(1):87–90. doi: 10.1002/sim.4780040112. [DOI] [PubMed] [Google Scholar]
  8. Fraser A. G., Sim R., Sankey E. A., Dhillon A. P., Pounder R. E. Effect of eradication of Helicobacter pylori on gastric epithelial cell proliferation. Aliment Pharmacol Ther. 1994 Apr;8(2):167–173. doi: 10.1111/j.1365-2036.1994.tb00274.x. [DOI] [PubMed] [Google Scholar]
  9. Garewal H. S., Sampliner R., Alberts D., Steinbronn K. Increase in ornithine decarboxylase activity associated with development of dysplasia in Barrett's esophagus. Dig Dis Sci. 1989 Feb;34(2):312–314. doi: 10.1007/BF01536068. [DOI] [PubMed] [Google Scholar]
  10. Golematis B., Tzardis P., Hatzikostas P., Papadimitriou K., Haritopoulos N. Changing pattern of distribution of carcinoma of the stomach. Br J Surg. 1990 Jan;77(1):63–64. doi: 10.1002/bjs.1800770123. [DOI] [PubMed] [Google Scholar]
  11. Graham D. Y. Campylobacter pylori and peptic ulcer disease. Gastroenterology. 1989 Feb;96(2 Pt 2 Suppl):615–625. doi: 10.1016/s0016-5085(89)80057-5. [DOI] [PubMed] [Google Scholar]
  12. Hansson L. E., Engstrand L., Nyrén O., Evans D. J., Jr, Lindgren A., Bergström R., Andersson B., Athlin L., Bendtsen O., Tracz P. Helicobacter pylori infection: independent risk indicator of gastric adenocarcinoma. Gastroenterology. 1993 Oct;105(4):1098–1103. doi: 10.1016/0016-5085(93)90954-b. [DOI] [PubMed] [Google Scholar]
  13. Hart-Hansen O., Johansen A., Larsen J. K., Svendsen L. B. Cell proliferation in normal and diseased gastric mucosa. Autoradiography after in vitro continuous labelling with tritiated thymidine. Acta Pathol Microbiol Scand A. 1979 May;87A(3):217–222. [PubMed] [Google Scholar]
  14. Heby O. Role of polyamines in the control of cell proliferation and differentiation. Differentiation. 1981;19(1):1–20. doi: 10.1111/j.1432-0436.1981.tb01123.x. [DOI] [PubMed] [Google Scholar]
  15. Kuipers E. J., Uyterlinde A. M., Peña A. S., Roosendaal R., Pals G., Nelis G. F., Festen H. P., Meuwissen S. G. Long-term sequelae of Helicobacter pylori gastritis. Lancet. 1995 Jun 17;345(8964):1525–1528. doi: 10.1016/s0140-6736(95)91084-0. [DOI] [PubMed] [Google Scholar]
  16. Luk G. D., Baylin S. B. Ornithine decarboxylase as a biologic marker in familial colonic polyposis. N Engl J Med. 1984 Jul 12;311(2):80–83. doi: 10.1056/NEJM198407123110202. [DOI] [PubMed] [Google Scholar]
  17. Luk G. D., Baylin S. B. Polyamines and intestinal growth--increased polyamine biosynthesis after jejunectomy. Am J Physiol. 1983 Nov;245(5 Pt 1):G656–G660. doi: 10.1152/ajpgi.1983.245.5.G656. [DOI] [PubMed] [Google Scholar]
  18. Lynch D. A., Mapstone N. P., Clarke A. M., Sobala G. M., Jackson P., Morrison L., Dixon M. F., Quirke P., Axon A. T. Cell proliferation in Helicobacter pylori associated gastritis and the effect of eradication therapy. Gut. 1995 Mar;36(3):346–350. doi: 10.1136/gut.36.3.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Narisawa T., Takahashi M., Niwa M., Koyama H., Kotanagi H., Kusaka N., Yamazaki Y., Nagasawa O., Koyama K., Wakizaka A. Increased mucosal ornithine decarboxylase activity in large bowel with multiple tumors, adenocarcinoma, and adenoma. Cancer. 1989 Apr 15;63(8):1572–1576. doi: 10.1002/1097-0142(19890415)63:8<1572::aid-cncr2820630821>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  20. Nomura A., Stemmermann G. N., Chyou P. H., Kato I., Perez-Perez G. I., Blaser M. J. Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med. 1991 Oct 17;325(16):1132–1136. doi: 10.1056/NEJM199110173251604. [DOI] [PubMed] [Google Scholar]
  21. O'Brien T. G. The induction of ornithine decarboxylase as an early, possibly obligatory, event in mouse skin carcinogenesis. Cancer Res. 1976 Jul;36(7 Pt 2):2644–2653. [PubMed] [Google Scholar]
  22. Parsonnet J., Friedman G. D., Vandersteen D. P., Chang Y., Vogelman J. H., Orentreich N., Sibley R. K. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med. 1991 Oct 17;325(16):1127–1131. doi: 10.1056/NEJM199110173251603. [DOI] [PubMed] [Google Scholar]
  23. Parsonnet J., Samloff I. M., Nelson L. M., Orentreich N., Vogelman J. H., Friedman G. D. Helicobacter pylori, pepsinogen, and risk for gastric adenocarcinoma. Cancer Epidemiol Biomarkers Prev. 1993 Sep-Oct;2(5):461–466. [PubMed] [Google Scholar]
  24. Patchett S. E., Alstead E. M., Butruk L., Przytulski K., Farthing M. J. Ornithine decarboxylase as a marker for premalignancy in the stomach. Gut. 1995 Jul;37(1):13–16. doi: 10.1136/gut.37.1.13. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Price A. B. The Sydney System: histological division. J Gastroenterol Hepatol. 1991 May-Jun;6(3):209–222. doi: 10.1111/j.1440-1746.1991.tb01468.x. [DOI] [PubMed] [Google Scholar]
  26. Rauws E. A., Langenberg W., Houthoff H. J., Zanen H. C., Tytgat G. N. Campylobacter pyloridis-associated chronic active antral gastritis. A prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology. 1988 Jan;94(1):33–40. [PubMed] [Google Scholar]
  27. Rozhin J., Wilson P. S., Bull A. W., Nigro N. D. Ornithine decarboxylase activity in the rat and human colon. Cancer Res. 1984 Aug;44(8):3226–3230. [PubMed] [Google Scholar]
  28. Sipponen P., Kekki M., Siurala M. Age-related trends of gastritis and intestinal metaplasia in gastric carcinoma patients and in controls representing the population at large. Br J Cancer. 1984 Apr;49(4):521–530. doi: 10.1038/bjc.1984.80. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Gut are provided here courtesy of BMJ Publishing Group

RESOURCES